Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange

Journal of Neurochemistry

Volumn 72, Issue 6, 1999, Pages 2379-2387

  Kearn, Christopher S ^a   Greenberg, Marcie J ^a   DiCamelli, Ralph ^a   Kurzawa, Kristen ^a   Hillard, Cecilia J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

9 Tetrahydrocannabinol; Anandamide; CP55940; HU210; Inverse agonist; Marijuana; N Arachidonylethanolamine; SR141716A; WIN 55212 2

Indexed keywords

CANNABINOID RECEPTOR; CANNABIS; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; GUANYLYLIMIDODIPHOSPHATE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CALCIUM CELL LEVEL; COMPETITIVE INHIBITION; CONFORMATIONAL TRANSITION; DRUG EFFICACY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALS; BINDING, COMPETITIVE; CANNABINOIDS; CELL MEMBRANE; CEREBELLUM; CYCLOHEXANOLS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; KINETICS; LIGANDS; MALE; PIPERIDINES; PYRAZOLES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL; TRITIUM;

EID: 0032973339     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0722379.x     Document Type: Article

References (41)

1. Bond R. A., Leff P., Johnson T. D., Milano C. A., Rockman H. A., McMinn T. R., Apparsundaram S., Hyek M. F., Kenakin T. P., Allen L. F., and Lefkowitz R. J. (1995) Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta2-adrenoceptor. Nature 374, 272-276.
2. Bouaboula M., Perrachon S., Milligan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Peccue F., Lupker J., Maffrand J.-P., Fur G. L., and Casellas P. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. J. Biol. Chem. 272, 22330-22339.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-252.
4. Breivogel C., Sim L., and Childers S. (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther. 282, 1632-1642.
5. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J. Biol. Chem. 273, 16865-16873.
6. Burkey T. H., Quock R. M., Consroe P., Roeske W. R., and Yamamura H. I. (1997a) Δ9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain. Eur. J. Pharmacol 323, R3-R4.
7. Burkey T. H., Quock R. M., Consroe P., Ehlert F. J., Hosohata Y., Roeske W. R., and Yamamura H. I. (1997b) Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Eur. J. Pharmacol. 336, 295-298.
8. Cheng Y. C. and Prusoff W. H. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 711-715.
9. Chidiac P., Hebert T. E., Valiquette M., Dennis M., and Bouvier M. (1994) Inverse agonist activity of beta-adrenergic antagonists. Mol. Pharmacol. 45, 490-499.
10. Childers S., Sexton T., and Roy M. (1994) Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47, 711-715.
11. Costa T. and Herz A. (1989) Antagonists with negative intrinsic activity at delta opiate receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. USA 86, 7321-7325.
12. Costa T., Ogino Y., Munson P. J., Onaran H. O., and Rodbard D. (1992) Drug efficacy at guanine nucleotide-binding regulator protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol 41, 549-560.
13. DeLean A., Stadel J. M., and Lefkowitz R. J. (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J. Biol. Chem. 255, 7108-7117.
14. Devanc W. A., Dysarz F. A., Johnson M. R., Melvin L. S., and Howlett A. C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 606-613.
15. Devane W., Breuer A., Sheskin T., Jarbe T., Eisen M., and Mechoulam R. (1992a) A novel probe for the cannabinoid receptor. J. Med. Chem. 35, 2065-2069.
16. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. (1992b) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
17. Gaoni Y. and Mechoulam R. (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646-1647.
18. Gerard C. M., Mollereau C., Vassart G., and Parmentier M. (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279, 129-134.
19. 35S]thio)-triphosphate binding assay in rat cerebellar membranes. J. Pharmacol. Exp. Ther. 285, 553-560.
20. Hilf G., Gierschik P., and Jacobs K. (1989) Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide binding proteins in cardiac membranes. Eur. J. Biochem. 186, 725-731.
21. Hillard C. J., Edgemond W. S., and Campbell W. B. (1995) Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. J. Neurochem. 64, 677-683.
22. Hirst R. A., Almond S., and Lambert D. (1996) Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist. Neurosci. Lett. 220, 101-104.
23. Howlett A. C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35, 607-634.
24. Kenakin T. (1995a) Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 16, 188-192.
25. Kenakin T. (1995b) Agonist-receptor efficacy. II: Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16, 232-238.
26. Kent R. S., DeLean A., and Lefkowitz R. J. (1980) A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol. Pharmacol. 17, 14-23.
27. Kuster J., Stevenson J., Ward S., D'Ambra T., and Haycock D. (1993) Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther. 264, 1352-1363.
28. Leff P. (1995) The two-state model of receptor activation. Trends Pharmacol. Sci. 16, 89-97.
29. Lefkowitz R. J., Cotecchia S., Samama P., and Costa T. (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14, 303-307.
30. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., and Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
31. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N. E., Schatz A. R., Gopher A., Almog S., Martin B. R., Compton D. R., Pertwee R. G., Griffin G., Bayewitch M., Barg J., and Vogel Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
32. Munro S., Thomas K. L., and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
33. Pacheco M. A., Ward S. J., and Childers S. R. (1993) Identification of cannabinoid receptors in cultures of rat cerebellar granule cells. Brain Res. 603, 102-110.
34. Petitet F., Jeantaud B., Capet M., and Doble A. (1997) Interaction of brain cannabinoid receptors with guanine nucleotide binding protein. Biochem. Pharmacol. 54, 1267-1270.
35. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinex S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrie P., Breliere J.-C., and LeFur G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
36. 3H]-SR141716A, a selective brain (CB1) cannabinoid receptor antagonist in rodent brain. Life Sci. 58, 1239-1247.
37. 35S]thio)triphosphate binding in rat brain membranes. Life Sci. 59, 659-668.
38. 35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. USA 92, 7242-7246.
39. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16, 8057-8066.
40. Thomas B. F., Gilliam A. F., Burch D. F., Roche M. J., and Seltzman H. H. (1998) Comparative receptor binding analyses of cannabinoid agonist and antagonists. J. Pharmacol. Exp. Ther. 285, 285-292.
41. Wieland T. and Jakobs K. (1994) Measurement of receptor-stimulated guanosine 5′-O-(γ-thio)triphosphate binding by G proteins. Methods Enzymol. 237, 3-26.